News

INSIGHTEC’S EXABLATE SYSTEM SPARES THE UTERUS WHEN TREATING UTERINE FIBROIDS

19
May

INSIGHTEC announced on Wednesday that the FDA has approved the relabelling of the Exablate system to treat women with symptomatic uterine fibroids who want to spare their uterus and maintain fertility. Exablate can now be used for both women who are “family complete” and those who still want to conceive. Link to article

More Articles

News
News

FDA OKS CHANGES FOR INSIGHTEC’S EXABLATE

News
News

FDA OKS CHANGES FOR INSIGHTEC’S EXABLATE

Font Resize